![Michael Entzeroth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Entzeroth
Geschäftsführer bei
Cennerv Pharmaceuticals Ltd.
Profil
Michael Entzeroth is currently the Chief Operating & Scientific Officer at Cennerv Pharmaceuticals Ltd. He previously worked as the Deputy Director-Global Alliances at the Agency for Science, Technology & Research from 2007 to 2013, and as the Managing Director at Pharma Resources Asia Pte Ltd. from 2006 to 2014.
He also served as the Vice President-New Technologies at Eurofins-Cerep SA from 1999 to 2002, and as the Head-Research Laboratory at Boehringer Ingelheim Pharma GmbH & Co., KG from 1985 to 1995.
Additionally, he briefly worked as the Chief Scientific Officer at S*BIO Pte Ltd. and Chakra Biotech Pte Ltd. Dr. Entzeroth received his undergraduate and doctorate degrees from Universität zu Köln in 1980 and 1983, respectively.
Aktive Positionen von Michael Entzeroth
| Unternehmen | Position | Beginn |
|---|---|---|
Cennerv Pharmaceuticals Ltd.
 Cennerv Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug development and distribution | Geschäftsführer | - |
Ehemalige bekannte Positionen von Michael Entzeroth
| Unternehmen | Position | Ende |
|---|---|---|
Pharma Resources Asia Pte Ltd. | Vorstandsvorsitzender | 01.12.2014 |
Chakra Biotech Pte Ltd. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2014 |
Agency for Science, Technology & Research
 Agency for Science, Technology & Research Miscellaneous Commercial ServicesCommercial Services Fosters scientific research and development | Corporate Officer/Principal | 01.07.2013 |
| EUROFINS CEREP | Corporate Officer/Principal | 01.09.2002 |
Boehringer Ingelheim Pharma GmbH & Co., KG
 Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Operates research-based pharmaceutical companies and serves | Corporate Officer/Principal | 01.02.1995 |
Ausbildung von Michael Entzeroth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Eurofins-Cerep SA
 Eurofins-Cerep SA Miscellaneous Commercial ServicesCommercial Services Offers preclinical drug discovery services | Commercial Services |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agency for Science, Technology & Research
Agency for Science, Technology & Research Miscellaneous Commercial ServicesCommercial Services Fosters scientific research and development | Commercial Services |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers novel targeted small molecule drugs | Health Technology |
Boehringer Ingelheim Pharma GmbH & Co., KG
Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Operates research-based pharmaceutical companies and serves | Health Technology |
Chakra Biotech Pte Ltd. | |
Cennerv Pharmaceuticals Ltd.
Cennerv Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug development and distribution | Health Technology |
Pharma Resources Asia Pte Ltd. |
